author-photo

Norman Wolmark

Allegheny Health Network

30

Papers

1030

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

NSABP B-41, a randomized neoadjuvant trial: Genes and signatures associated with pathologic complete response (pCR).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
GeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—First experimental arm (EA) initial results.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (14)
Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

2019 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (42)
Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer: NSABP FR-2.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A phase II clinical trial platform for sensitization testing using total neoadjuvant therapy (TNT) in rectal cancer: Nrg-GI002.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab

2018 Pharmacogenetics and Genomics
Show All
- Source
- Cite
- Save
Citations (2)
NRG Oncology BR005: Phase II trial assessing accuracy of tumor bed biopsies (Bx) in predicting pathologic response in patients (Pts) with clinical/radiological complete response (CR) after neoadjuvant chemotherapy (NCT) in order to explore the feasibility of breast-conserving treatment (BCT) without surgery.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
NRG Oncology/NSABP B-31: Stromal tumor infiltrating lymphocytes (sTILs) and outcomes in early-stage HER2-positive breast cancer (BC).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)